Bariatric Surgery Segmentation
Procedure Type (Sleeve Gastrectomy, Gastric Bypass, Adjustable Gastric Band, Biliopancreatic Diversion with Duodenal Switch)
Based on procedure type, the sleeve gastrectomy segment is expected to garner the highest share of 48.2% in the bariatric surgery market by the end of 2037. The dominance of the segment is facilitated by its low complication rates, 5.8% when compared to gastric bypass, which is 9.8%. Besides, the U.S. FDA approved robotic-assisted sleeves in 2023 that significantly boosted adoption by 26%. Furthermore, CMS states that Medicare covers over 88% of sleeve procedures, thus providing an optimistic outlook for the segment’s dominance.
End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics)
Based on end user, the ambulatory surgical centers segment is anticipated to grow at a considerable rate, with a share of 42.5% in the bariatric surgery market during the forecast timeline. The growth in the segment is subject to its affordability when compared to hospitals offering a 42% cost reduction. Besides the UnitedHealthcare-imposed mandates, ASCs for bariatric surgery thereby increased procedural volumes by 35%. Further, it offers a reduced recovery timeframe when compared to hospitals, hence effectively contributing to the segment’s growth.
Our in-depth analysis of the global market includes the following segments:
|
Procedure type |
|
|
Device Type |
|
|
End user |
|
